Teligent - TEL 0127AJ02 - EA/1 LIDOCAINE HCI INJECTION 2% PLAIN W/ PRESERVATIVE 50ml VIAL

Product Description

What this product is and who it is for

• This is a 50 mL multi‑dose vial of lidocaine hydrochloride injection, 2% (20 mg/mL), with methylparaben preservative. It is intended for local anesthesia (for example infiltration and peripheral nerve block) and is supplied for clinical use by licensed health professionals.

Specifications

• Concentration: 2% (20 mg lidocaine HCl per mL).
• Nominal volume: 50 mL per vial (1000 mg total lidocaine HCl).
• Preservative: methylparaben included (manufacturer labeling lists 1 mg methylparaben per mL).
• Presentation: multi‑dose, amber glass vial (packaged as single vial).
• Intended users: prescription only — for administration by qualified healthcare personnel.

What is included

• 1 x 50 mL multi‑dose glass vial containing Lidocaine HCl 2% with methylparaben.
• No syringes, needles, diluents or single‑use administration devices are included unless explicitly stated on the seller listing.

Condition and packaging

• Product is sold new/manufacturer sealed as a sterile injectable solution in a multi‑dose amber glass vial where labelled. The photographs provided with this brief did not show the product label; identification relies on the seller/manufacturer product data.

Usage notes

• For parenteral/infiltration/nerve block techniques only; follow institutional protocols for dose, dilution and administration.
• Do not use preservative‑containing local anesthetic solutions for spinal/epidural (intrathecal) administration — verify route before use.
• Store according to manufacturer label; check carton/label for storage temperature and expiry before use.

Limitations and who this is NOT suitable for

• Not for epidural or spinal anesthesia when preservative is present.
• Not for use by non‑medical consumers; prescription/medical administration only.

Warnings

• Confirm the vial label (manufacturer, lot, expiry) on receipt; the product photograph supplied with this request did not display the vial label, so buyers should verify label details prior to use.
• There has been at least one unrelated recall history for a Teligent topical lidocaine product (topical 4%), so purchasers should confirm product form and lot status with the manufacturer or their wholesaler before clinical use.
• If evidence about a specific labeler/lot is required (e.g., for regulatory or hospital stocking purposes), request copies of the manufacturer’s certificate of analysis or supplier documentation before purchase.

If information is unknown

• Some sellers do not display the exact vial closure type or carton contents online; if closure type (flip‑top vs. other), supplied leaflet, or pack quantity is required for your workflow, request those specifics from the supplier before ordering.